Table 3.
Left hemisphere stroke (n=12, FMUE=45.2±19.1, time after stroke=32.7±28.4mo) | Right hemisphere stroke (n=6, FMUE=38.5±11.6, time after stroke=46.8±51.6mo) | p-value | |
---|---|---|---|
N-acetylaspartate (mM) | |||
Ipsilesional | 9.6±1.6 | 9.3±1.1 | .7 |
Contralesional | 11.3±1.6 | 10.1±1.5 | .8 |
Spatial extent of activation (%) | |||
Ipsilesional | 22.5±14.4 | .1 | |
Contralesional | 11.7±11.9 | 15.7±10.3 | .5 |
PLIC stroke (n=7, FMUE=43.4±18.8, time after stroke=47.0±47.4mo) | ALIC stroke (n=3, FMUE=50.3±9.5, time after stroke=32.0±24.9mo) | p-value | |
---|---|---|---|
N-acetylaspartate (mM) | |||
Ipsilesional | 9.3±1.4 | 9.3±1.2 | .9 |
Contralesional | 9.6±1.6 | 10.9±1.5 | .2 |
Spatial extent of activation (%) | |||
Ipsilesional | 19.3±16.8 | 16.6±12.4 | .8 |
Contralesional | 11.8±12.1 | 2.4±2.2 | .2 |
n, number of patients; FMUE, Fugl-Meyer Upper Extremity, mo, months